Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Market News
Why the Starpharma (ASX:SPL) share price raced higher today
Share Market News
Starpharma (ASX:SPL) share price sinks 5% despite new board member
Share Gainers
Why the Starpharma (ASX:SPL) share price is racing 7% higher today
Share Fallers
Why Codan, CommBank, Rio Tinto, & Starpharma shares are sinking
Healthcare Shares
Why the Starpharma (ASX:SPL) share price is down 10% today
Share Gainers
Why Afterpay, Betmakers, Bubs, & Starpharma shares are racing higher
Share Gainers
Starpharma (ASX:SPL) share price jumps 7% on COVID variant update
Share Market News
Starpharma (ASX:SPL) share price rebounds after receiving Indian approval for COVID-19 product
Share Gainers
Starpharma (ASX:SPL) share price pushes higher on COVID-19 product update
Healthcare Shares
The Starpharma (ASX:SPL) share price is 35% below its 52-week high
Share Market News
The ASX shares poised to benefit from new spending in the 2021 federal budget
Coronavirus News
Starpharma (ASX:SPL) share price slides despite COVID spray rugby deal
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
